Duggan DB - Search Results

1

A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.

Weiss RB, Peterson BL, Allen SL, Browning SM, Duggan DB, Schiffer CA. Weiss RB, et al. Among authors: duggan db. Invest New Drugs. 1994;12(1):41-3. doi: 10.1007/BF00873234. Invest New Drugs. 1994. PMID: 7960604 Clinical Trial.

2

High dose toremifene for estrogen and progesterone receptor negative metastatic breast cancer: a phase II trial of the Cancer and Leukemia Group B (CALGB).

Perry JJ, Berry DA, Weiss RB, Hayes DM, Duggan DB, Henderson IC. Perry JJ, et al. Among authors: duggan db. Breast Cancer Res Treat. 1995;36(1):35-40. doi: 10.1007/BF00690182. Breast Cancer Res Treat. 1995. PMID: 7579504 Clinical Trial.

3

A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.

Cooper MR, Dear K, McIntyre OR, Ozer H, Ellerton J, Canellos G, Bernhardt B, Duggan D, Faragher D, Schiffer C. Cooper MR, et al. J Clin Oncol. 1993 Jan;11(1):155-60. doi: 10.1200/JCO.1993.11.1.155. J Clin Oncol. 1993. PMID: 8418228 Clinical Trial.

4

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.

Parnes HL, Abrams JS, Tait N, Minford J, Allen SL, Duggan D, Aisner J. Parnes HL, et al. J Natl Cancer Inst. 1991 Jul 17;83(14):1017-20. doi: 10.1093/jnci/83.14.1017. J Natl Cancer Inst. 1991. PMID: 2072408 Clinical Trial.

5

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Parnes HL, Cirrincione C, Aisner J, Berry DA, Allen SL, Abrams J, Chuang E, Cooper MR, Perry MC, Duggan DB, Szatrowski TP, Henderson IC, Norton L; Cancer and Leukemia Group B. Parnes HL, et al. Among authors: duggan db. J Clin Oncol. 2003 May 1;21(9):1819-24. doi: 10.1200/JCO.2003.05.119. J Clin Oncol. 2003. PMID: 12721259 Clinical Trial.

6

Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.

Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan DB, Weiss RB, Royston I, Millard FE, et al. Newman RA, et al. Among authors: duggan db. Blood. 1993 Aug 15;82(4):1239-46. Blood. 1993. PMID: 8102560 Free article.

7

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP. Costanza ME, et al. Clin Cancer Res. 1995 Jul;1(7):699-704. Clin Cancer Res. 1995. PMID: 9816035 Clinical Trial.

8

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.

Graziano SL, Herndon JE 2nd, Richards F 2nd, DiFino S, Modeas C, Duggan DB, Green MR. Graziano SL, et al. Among authors: duggan db. Cancer. 1993 Jul 1;72(1):62-8. doi: 10.1002/1097-0142(19930701)72:1<62::aid-cncr2820720114>3.0.co;2-e. Cancer. 1993. PMID: 8389667 Clinical Trial.

9

Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.

Liu MC, Demetri GD, Berry DA, Norton L, Broadwater G, Robert NJ, Duggan D, Hayes DF, Henderson IC, Lyss A, Hopkins J, Kaufman PA, Marcom PK, Younger J, Lin N, Tkaczuk K, Winer EP, Hudis CA; Cancer and Leukemia Group B. Liu MC, et al. Cancer Treat Rev. 2008 May;34(3):223-30. doi: 10.1016/j.ctrv.2007.11.004. Epub 2008 Jan 30. Cancer Treat Rev. 2008. PMID: 18234424 Free PMC article. Clinical Trial.

10

Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.

Canellos GP, Petroni GR, Barcos M, Duggan DB, Peterson BA. Canellos GP, et al. Among authors: duggan db. J Clin Oncol. 1995 Aug;13(8):2005-11. doi: 10.1200/JCO.1995.13.8.2005. J Clin Oncol. 1995. PMID: 7636541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page